Evaluation of antiviral compounds by suppression of tail lesions in vaccinia-infected mice.
D000547:Amantadine / Q000627:therapeutic use; D000818:Animals; D000998:Antiviral Agents / Q000627:therapeutic use*; D002511:Cephalosporins / Q000627:therapeutic use; D003872:Dermatitis / Q000188:drug therapy*; D006146:Guanidines / Q000627:therapeutic use; D007065:Idoxuridine / Q000627:therapeutic use; D051379:Mice; D013882:Thiosemicarbazones / Q000627:therapeutic use; D014616:Vaccinia virus
D000998:Antiviral Agents; D002511:Cephalosporins; D006146:Guanidines; D013882:Thiosemicarbazones; D000547:Amantadine; D007065:Idoxuridine